The experimental evidence of the antioxidative and anti-inflammatory properties of apoA-IV as shown for atherosclerosis in mice [13–15] may also explain the association of increased apoA-IV concentrations and lower number of cancer outcomes and cancer death in the GCKD study. The gene discussed is APOA4; the disease is cancer.